Resistin is a prognostic factor for death in type 2 diabetes.

Agnieszka Kapłon-CieślickaKrzysztof OzierańskiMarek RosiakKrzysztof OzierańskiMichał PellerCeren EyiletenAgnieszka KondrackaJustyna PordzikDagmara Mirowska-GuzelGrzegorz OpolskiMarek PostułaKrzysztof J Filipiak

Published in: Diabetes/metabolism research and reviews (2018)

Higher resistin is associated with reduced survival in T2D, irrespectively of TNF-α. Resistin concentration of above 11 ng/mL indicates T2D patients at an increased risk of unfavourable outcomes. Leptin was not a prognostic factor. These results suggest that in T2D, association of resistin with unfavourable outcomes might, at least in part, result from its pro-inflammatory properties.

Keyphrases

prognostic factors
type diabetes
glycemic control
rheumatoid arthritis
insulin resistance
metabolic syndrome